Published in PLoS One on August 25, 2015
The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications. Prog Retin Eye Res (2017) 0.76
iTRAQ-based quantitative proteomic analysis of Yamanaka factors reprogrammed breast cancer cells. Oncotarget (2017) 0.75
In-depth proteomic profiling of the uveal melanoma secretome. Oncotarget (2016) 0.75
Measurement of protein using bicinchoninic acid. Anal Biochem (1985) 74.03
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature (2008) 8.42
Mutations in GNA11 in uveal melanoma. N Engl J Med (2010) 7.52
Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics (2004) 4.09
Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology (2011) 3.52
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn (2010) 2.48
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest (2005) 2.38
Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch Toxicol (2012) 2.04
Prognosis and treatment of disseminated uveal melanoma. Cancer (1993) 1.98
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol (2006) 1.93
Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell (2003) 1.81
The dynamic nature of Bruch's membrane. Prog Retin Eye Res (2009) 1.71
Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res (2007) 1.71
Systematic comparison of label-free, metabolic labeling, and isobaric chemical labeling for quantitative proteomics on LTQ Orbitrap Velos. J Proteome Res (2012) 1.50
The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med (2007) 1.50
beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression. Proc Natl Acad Sci U S A (2010) 1.40
The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res (2012) 1.39
Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci (2009) 1.25
The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9. Am J Ophthalmol (1998) 1.23
Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci (2010) 1.23
Evidence that light modulates protein nitration in rat retina. Mol Cell Proteomics (2002) 1.22
Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes. Mol Cell Proteomics (2010) 1.22
Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res (1996) 1.20
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proc Natl Acad Sci U S A (2012) 1.12
Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. J Proteome Res (2005) 1.10
Molecular prognostic testing and individualized patient care in uveal melanoma. Am J Ophthalmol (2009) 1.07
The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer (2006) 1.05
Quantitative proteomics: TGFβ₂ signaling in trabecular meshwork cells. Invest Ophthalmol Vis Sci (2011) 1.02
Members of the fatty acid binding protein family are differentiation factors for the mammary gland. J Cell Biol (1994) 1.01
Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem Biophys Res Commun (2006) 1.01
Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum. J Proteome Res (2007) 0.96
The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci (2014) 0.92
Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer. Surgery (2011) 0.92
CEP biomarkers as potential tools for monitoring therapeutics. PLoS One (2013) 0.92
Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis. Mol Cell Proteomics (2009) 0.92
Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux. World J Gastroenterol (2005) 0.89
Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not. Invest Ophthalmol Vis Sci (2012) 0.89
Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction. Angiogenesis (2012) 0.88
Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma. Cancer Res (2012) 0.88
Proteomic similarities in steroid responsiveness in normal and glaucomatous trabecular meshwork cells. Mol Vis (2012) 0.87
Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression. Invest Ophthalmol Vis Sci (2006) 0.85
Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array. Invest Ophthalmol Vis Sci (2012) 0.85
Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Invest Ophthalmol Vis Sci (2009) 0.84
Preliminary quantitative proteomic characterization of glaucomatous rat retinal ganglion cells. Exp Eye Res (2010) 0.84
HSP-27 protein expression in uveal melanoma: correlation with predicted survival. Acta Ophthalmol (2010) 0.84
Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma. J Gastrointest Surg (2013) 0.82
HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins. Cancers (Basel) (2014) 0.82
MMP9 processing of HSPB1 regulates tumor progression. PLoS One (2014) 0.82
Quantitative proteomic analysis for radiation-induced cell cycle suspension in 92-1 melanoma cell line. J Radiat Res (2013) 0.81
Overexpression of collagen VI α3 in gastric cancer. Oncol Lett (2014) 0.81
Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract (2010) 0.80
Proteomics in uveal melanoma. Melanoma Res (2003) 0.80
Proteomic analysis of energy metabolism and signal transduction in irradiated melanoma cells. Int J Ophthalmol (2013) 0.79
Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS. Proteomics (2005) 0.79
Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery. Expert Rev Proteomics (2007) 0.78
Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma. Invest Ophthalmol Vis Sci (2015) 0.78
Proteomics of uveal melanoma: a minireview. J Oncol (2013) 0.76
Proteomics in uveal melanoma. Exp Eye Res (2013) 0.76